Trocoxil - Advancing Chronic Pain Management
(incl. tax)
Trocoxil is a long acting Non-Steroidal Anti-Inflammatory indicated for dogs with Degenerative Joint Disease. This revolutionary medication represents the veterinary practitioner’s best chance to implement a ‘best practice’ approach in continuously relieving the pain and suffering of chronic osteoarthritis in dogs without compromising patient safety. Trocoxil has been available in Australia for a number of years. This presentation will address the compelling reasons for Trocoxil usage, give insight to the Australian experience of the product’s safety, and allow ample opportunity for questions.
This webinar is organised in co-operation with Vetlink Media Solutions and sponsored by Zoetis.
Recording from 29.05.2018
Richard L’Estrange BVSc (hons) MANZCVS (Vet Pharmacology)
Richard L’Estrange is a 1987 graduate of the University of Queensland. He worked in mixed and small animal practices in South East QLD and the UK before purchasing a Small Animal practice in Brisbane in 1996. Membership of the Australian College of Veterinary Scientists in Veterinary Pharmacology was achieved in 2008. After 22 years of general practice he sold his practice and entered Industry in February 2010 as a Technical Services Veterinarian with what was then Pfizer Animal Health, but is now Zoetis. He is one of a team of vets within the Companion Animal Business of Zoetis Australia and been an integral part of the launches of many recent products in Australia, including Trocoxil.
You might also be interested in
Introducing the new ACVIM consensus statement for status epilepticus
ECG during Anaesthesia: Interpret and Respond with Confidence
